STOCK TITAN

Brunswick Corp (NYSE: BC) grants director 740 deferred shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BRUNSWICK CORP director David C. Everitt received a grant of 740 deferred shares of common stock on 2026-07-31 at $79 per share. These deferred shares are deposited in his director deferred account and will be distributed in predetermined installments after he ceases being a director, bringing his direct holdings to 39,908 shares, including 203 shares acquired through dividend reinvestments through June 2026.

Positive

  • None.

Negative

  • None.
Insider EVERITT DAVID C
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1, F2 740 $79.00 $58K
Holdings After Transaction: Common Stock — 39,908 shares (Direct)
Footnotes (2)
  1. F1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
  2. F2. Beneficial holdings include 203 shares acquired pursuant to dividend reinvestments through June 2026.
Deferred shares awarded 740 shares Grant of deferred common stock to director on 2026-07-31
Award price per share $79.00 per share Valuation used for the director’s deferred share grant
Total direct holdings after award 39,908 shares Director’s direct common stock holdings following the transaction
Dividend reinvestment shares included 203 shares Portion of beneficial holdings from dividend reinvestments through June 2026
Deferred shares financial
"Deferred shares deposited in the director's deferred account"
Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.
dividend reinvestments financial
"shares acquired pursuant to dividend reinvestments through June 2026"
beneficial holdings financial
"Beneficial holdings include 203 shares acquired pursuant to dividend"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Brunswick (BC) director David C. Everitt report?

David C. Everitt reported receiving a grant of 740 deferred shares of Brunswick common stock at $79 per share on 2026-07-31. The award is a compensatory grant credited to his director deferred account rather than an open-market purchase.

How many Brunswick (BC) shares does David C. Everitt hold after this award?

Following the award, David C. Everitt directly holds 39,908 Brunswick common shares. This total explicitly includes 203 shares that were acquired through dividend reinvestments completed through June 2026, as noted in the filing’s footnote.

What are deferred shares in Brunswick (BC)'s director award?

The filing describes the granted stock as deferred shares deposited in the director’s deferred account. These shares will be automatically distributed in predetermined installments after Everitt ceases being a director of the company, rather than delivered immediately.

Does David C. Everitt’s Brunswick (BC) holding include dividend reinvestments?

Yes. The footnote states his beneficial holdings include 203 shares acquired through dividend reinvestments through June 2026. These reinvested shares are part of the reported 39,908 direct common shares he beneficially owns after the transaction.

Was the Brunswick (BC) director’s deferred share award under a Rule 10b5-1 plan?

The Form 4’s Rule 10b5-1 checkbox is not marked for this transaction. The reported activity is a grant (code A) of deferred shares as director compensation, not an open-market trade executed under a trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
EVERITT DAVID C

(Last)(First)(Middle)
C/O BRUNSWICK CORPORATION
26125 N. RIVERWOODS BLVD. SUITE 500

(Street)
METTAWA ILLINOIS 60045

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026A740(1)A$7939,908(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
2. Beneficial holdings include 203 shares acquired pursuant to dividend reinvestments through June 2026.
Remarks:
By: Power of Attorney For: /s/ David C. Everitt08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)